Home › Peptides › KLOW (80 mg Vial)
KLOW (80 mg Vial) dosage and protocol
Last reviewed Mar 26, 2026. Editorial policy
KLOW is a proprietary peptide blend designed to support weight management, metabolic regulation, and GLP-1 receptor pathway modulation. The 80mg vial format suggests a high-concentration formulation intended for extended use or higher dose protocols targeting appetite suppression, fat loss, and metabolic improvements.
- Vial size: 80 mg
- Reconstitution: 3 mL bacteriostatic water
- Concentration: 26.67 mg/mL
- Administration: subcutaneous
Research areas
- Weight Management
- Metabolic Health
- Appetite Suppression
- Fat Loss
- GLP-1 Pathway
Quick start
- Reconstitute: Add 3.0mL bacteriostatic water → ~26.67mg/mL concentration
- Typical dose: Per protocol — consult specific blend component dosing
- Storage: Lyophilized at −20°C; reconstituted refrigerated at 2–8°C; use within 4 weeks
Dosing protocol
| Phase | Dose | Frequency | Volume |
|---|---|---|---|
| Titration | Per component protocol | Weekly or bi-weekly | Per component protocol |
How it works
KLOW is a blend formulation targeting multiple metabolic pathways simultaneously. Components typically work through appetite-regulating, insulin-sensitizing, and fat-oxidizing mechanisms to produce comprehensive metabolic improvements beyond what single compounds achieve.
Units chart for a 80 mg vial
| Water added | Strength | 1 unit = | 100 mcg | 250 mcg | 500 mcg |
|---|---|---|---|---|---|
| 1 mL | 80 mg/mL | 800 mcg | 0.1 units | 0.3 units | 0.6 units |
| 2 mL | 40 mg/mL | 400 mcg | 0.3 units | 0.6 units | 1.3 units |
| 3 mL | 26.67 mg/mL | 266.7 mcg | 0.4 units | 0.9 units | 1.9 units |
Units on a U-100 insulin syringe (100 units = 1 mL).
Pages for each vial size and water volume
Reconstitution steps
- Draw 3.0mL bacteriostatic water with a sterile syringe
- Inject slowly down the vial wall; avoid foaming
- Gently swirl/roll until dissolved (do not shake)
- Label concentration (~26.67mg/mL) and date; refrigerate at 2–8°C
Storage
Lyophilized: store at −20°C. After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
Important notes
- Research use only
- Blend formulation — review individual component profiles before use
- Titrate conservatively due to multi-compound nature
- Monitor for GI effects common with metabolic peptide blends
- Rotate injection sites to prevent irritation
Supplies
- KLOW vial (80mg)
- Bacteriostatic water (10mL)
- Insulin syringes (U-100)
- Alcohol swabs
- Sharps container